Christian Fink, MD

Pulmonary embolism is a common, potentially life-threatening condition.1 Diagnosing PE remains a major challenge because typical symptoms such as dyspnea, tachycardia, acute chest pain, and syncope are unspecific and may not be present in all patients. Imaging therefore plays a pivotal role in establishing a diagnosis.2

Non-small cell lung cancer is the leading cause of cancer-related deaths in women and men in the Western Hemisphere. Surgical resection remains the mainstay of therapy in disease at stages I and II, and this treatment has an acceptable morbidity and mortality rate. Imaging is needed for effective treatment planning and accurate diagnosis, including preoperative assessment of resectability.